Physician profile
Michael Shapiro
NPI 1184888968
$54,409.08
in general payments reported to CMS, 2019-2025
13 companies · $15K in 2025
The $15K reported for 2025 was more than what 93% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $593 · 2020: $40.29 · 2021: $634 · 2022: $11K · 2023: $10K · 2024: $17K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $42K · Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $41,833.33 |
| Food and Beverage | $719.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $52,322.91 | 2021-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| W. L. Gore & Associates, INC. | $481.13 | 2019 | |
| Medtronic, INC. | $392.56 | 2021-2025 | Closurefast, Endurant Iis |
| Terumo Medical Corporation | $305.75 | 2021-2025 | Navicross, R2p Misago |
| Cvrx, INC. | $247.53 | 2022-2023 | Barostim Neo System |
| Abbott Laboratories | $203.16 | 2023-2024 | Diamondback Peripheral, Esprit, Perclose Proglide |
| Boston Scientific Corporation | $166.30 | 2023 | |
| Endologix LLC | $152.06 | 2019-2021 | |
| Shockwave Medical, INC | $45.60 | 2025 | |
| Nuvasive, INC. | $40.29 | 2020 | |
| Bard Peripheral Vascular, INC. | $22.16 | 2025 | Ultraverse 014 |
| Sun Pharmaceutical Industries INC. | $19.96 | 2022 | |
| Penumbra, INC. | $9.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.